首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1907998

阿片类药物市场按药物类别、用途、给药途径、分销管道和地区划分

Opioid Drugs Market, By Drug Class, By Application, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2025年12月24日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计到 2025 年，鸦片类药物市场价值将达到 480.2 亿美元，到 2032 年将达到 602.7 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 3.3%。

报告覆盖范围		报告详情
基准年：	2024	2025年市场规模：	480.2亿美元
历史数据时期：	2020年至2024年	预测期：	2025年至2032年
预测期（2025-2032年）复合年增长率：	3.30%	2032 年的预测值：	602.7亿美元

阿片类药物是一类主要用于缓解疼痛的药物。氢可酮是最早的鸦片类药物之一，于1803年研发成功。鸦片类药物作用于中枢和周边神经系统中的鸦片受体，进而缓解疼痛。阿片类药物的给药途径包括口服片剂、注射剂、液体剂型、贴片和锭剂。处方笺鸦片类药物包括Fentanyl、羟考酮、氢可酮、可待因、oxymorphone和氢可酮，由医生开立用于疼痛管理。

市场动态

针对阿片受体和神经激肽受体的杂合化合物合成的研究与开发不断加强，预计将为市场相关人员创造盈利的成长机会。例如，2019年12月，罗兹医科大学的研究人员报告了一系列杂合化合物的合成、构效关係和药理学表征，这些化合物将阿片类药物的药理基团与P物质（SP）片段或神经激肽受体（NK1）拮抗剂片段相结合，探讨了神经激肽系统在阿片类药物诱导的镇痛作用中的作用。

市场上的主要企业正专注于产品核可和上市，以拓展产品系列。例如，2018年6月，专业製药公司AcelRx Pharmaceuticals, Inc.的DZUVEO获得欧盟委员会（EC）核准，用于在医疗监督下治疗成人急性中度至重度疼痛。此外，市场併购活动也正在增加。例如，Grunenthal收购了美国製药公司Averitas Pharma，以拓展其在美国的业务。

本次调查的主要特点

本报告以 2024 年为基准年，介绍了全球鸦片类药物市场的规模，并对 2025 年至 2032 年的预测期进行了详细分析。
它重点介绍了各个细分市场的潜在商机，并说明了该市场具有吸引力的投资提案矩阵。
该研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或核准、区域前景以及主要企业采取的竞争策略的重要见解。
该报告根据以下参数对全球阿片类药物市场的主要企业进行了分析：公司概况、财务业绩、产品系列、地理分布、分销策略、关键发展和策略以及未来计划。
本报告的研究结果将帮助负责人和经营团队就未来的产品推出、技术升级、市场扩张和行销策略做出明智的决策。
这份全球阿片类药物市场报告的目标受众是该行业的各类相关人员，包括投资者、供应商、製造商、经销商、新参与企业和金融分析师。
相关人员可以透过各种用于分析全球阿片类药物市场的策略矩阵轻鬆做出决策。

北美洲
- 美国
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲国家
欧洲
- 英国
- 德国
- 义大利
- 法国
- 西班牙
- 俄罗斯
- 其他欧洲
亚太地区
- 中国
- 印度
- 日本
- ASEAN
- 澳洲
- 韩国
- 其他亚太地区
中东
- GCC
- 以色列
- 其他中东地区
非洲
- 北非
- 中非
- 南非

第九章竞争情势

公司简介
- Teva Pharmaceutical Industries Ltd.
- Johnson &Johnson
- Endo International plc
- Lupin Limited
- Cadila Healthcare Limited
- Purdue Pharma LP
- AbbVie Inc.
- Fresenius Kabi
- Mallinckrodt Pharmaceuticals
- Pfizer Inc.
- Rhodes Pharmaceuticals LP
- Sun Pharmaceutical Industries Limited
- Nesher Pharmaceuticals（USA）LLC
- Amneal Pharmaceuticals LLC
- Trevena Inc.
- Aurobindo Pharma Limited

第十章各节

参考
调查方法

简介目录

Product Code: CMI1017

Opioid Drugs Market is estimated to be valued at USD 48.02 Bn in 2025 and is expected to reach USD 60.27 Bn by 2032, growing at a compound annual growth rate (CAGR) of 3.3% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 48.02 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	3.30%	2032 Value Projection:	USD 60.27 Bn

Opioids are a class of drugs which are largely used for relieving pain. One of the first opioid drugs 'morphine' was developed in 1803. Opioid drugs act on the opioid receptors present in the central and peripheral nervous system thus providing relief from pain. Opioid are administered in the form of as oral pills, parenteral, liquids, patches or lozenges. There are different types of prescription opioids available such as fentanyl, oxycodone, morphine, codeine, oxymorphone, and hydrocodone which are prescribed by physicians for treating pain.

Market Dynamics

Increasing R&D in synthesis of hybrids targeting opioid and neurokinin receptors is expected to offer lucrative growth opportunities for market players. For instance, in December 2019, researchers from Medical University of Lodz reported the synthesis, structure-activity relationship, and pharmacological characterization of a series of hybrids combining opioid pharmacophores with either substance P (SP) fragments or neurokinin receptor (NK1) antagonist fragments in order to comprehend the role of the neurokinin system in opioid-induced antinociception.

Key players in the market are focused on product approvals and launches to expand their product portfolio. For instance, in June 2018, AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company received the European Commission (EC) approval for DZUVEO for the management of acute moderate to severe pain in adults in medically monitored settings. The market is witnessing increasing merger and acquisition activities. For instance, Grunenthal acquired the U.S.-based pharmaceutical company 'Averitas Pharma' in order to expand its presence in the U.S.

Key features of the study

This report provides an in-depth analysis of global opioids market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global opioids market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Johnson & Johnson, Endo International plc, Lupin Limited, Cadila Healthcare Limited, Purdue Pharma L.P., AbbVie Inc., Fresenius Kabi, Mallinckrodt Pharmaceuticals, Pfizer Inc., Rhodes Pharmaceuticals L.P., Sun Pharmaceutical Industries Limited, Nesher Pharmaceuticals (USA) LLC, Amneal Pharmaceuticals LLC, Trevena Inc., and Aurobindo Pharma Limited
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global opioids market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global opioids market

Market Segmentation

Drug Class Insights (Revenue, USD Bn, 2025 - 2032)
- Alkaloids
- Semisynthetic Opioids
- Synthetic Opioids
Application Insights (Revenue, USD Bn, 2025 - 2032)
- Analgesia
- Cough Suppression
- Diarrhea Suppression
Route of Administration Insights (Revenue, USD Bn, 2025 - 2032)
- Oral
- Topical
- Parenteral
- Others
Distribution Channel Insights (Revenue, USD Bn, 2025 - 2032)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Insights (Revenue, USD Bn, 2025 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Key Players Insights
- Teva Pharmaceutical Industries Ltd.
- Johnson & Johnson
- Endo International plc
- Lupin Limited
- Cadila Healthcare Limited
- Purdue Pharma L.P.
- AbbVie Inc.
- Fresenius Kabi
- Mallinckrodt Pharmaceuticals
- Pfizer Inc.
- Rhodes Pharmaceuticals L.P.
- Sun Pharmaceutical Industries Limited
- Nesher Pharmaceuticals (USA) LLC
- Amneal Pharmaceuticals LLC
- Trevena Inc.
- Aurobindo Pharma Limited

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Application
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
Reimbursement Scenario
PEST Analysis
PORTER'S Analysis

4. Global Opioid Drugs Market, By Drug Class, 2020- 2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Alkaloids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Segment Trends
  - Morphine
  - codeine
Semisynthetic Opioids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Segment Trends
  - Oxycodone
  - Hydrocodone
  - Hydromorphone
Synthetic Opioids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Segment Trends
  - Fentanyl
  - Alfentanil

5. Global Opioid Drugs Market, By Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Analgesia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Segment Trends
Cough Suppression
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Segment Trends
Diarrhea Suppression
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Segment Trends

6. Global Opioid Drugs Market, By Route of Administration, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Segment Trends
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Segment Trends
Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Segment Trends
Others (Intramuscular, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Segment Trends

7. Global Opioid Drugs Market, By Distribution Channel, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Opioid Drugs Market, By Region, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
North America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2020-2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Teva Pharmaceutical Industries Ltd.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Johnson & Johnson
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Endo International plc
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Lupin Limited
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Cadila Healthcare Limited
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Purdue Pharma L.P.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- AbbVie Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Fresenius Kabi
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Mallinckrodt Pharmaceuticals
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Pfizer Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Rhodes Pharmaceuticals L.P.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Sun Pharmaceutical Industries Limited
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Nesher Pharmaceuticals (USA) LLC
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Amneal Pharmaceuticals LLC
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Trevena Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Aurobindo Pharma Limited
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies

10. Section

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

阿片类药物市场按药物类别、用途、给药途径、分销管道和地区划分

Opioid Drugs Market, By Drug Class, By Application, By Route of Administration, By Distribution Channel, By Geography

市场动态

目录

第一章研究目标与前提条件

第二章市场范围

第三章市场动态、监理及趋势分析

4. 2020-2032年全球鸦片类药物市场（依药物类别划分）

5. 2020-2032年全球鸦片类药物市场（依应用领域划分）

6. 2020-2032年全球鸦片类药物市场（依给药途径划分）

7. 2020-2032年全球鸦片类药物市场依分销管道划分

8. 2020-2032年全球鸦片类药物市场（依地区划分）